Trade Filings
Managers Stocks Filings Superinvestors
Signals Institutional Buying Institutional Selling Insider Activity 13D & 13G Watch Sector Rotation
Tools Stock Screener Manager Screener Compare Managers Consensus Baskets All Research Tools Data API
Learn & AI Learn Ask the Data AI Agents
News ★ Saved
About About us Methodology Contact Disclaimer
Reader
DATA PLANS

Historical data downloads — coming with accounts.

API GATEWAY

Free read-only JSON access to the site's cached data.

Dark mode

🧭 Guided View
New to markets — prices, yields, YTD, market cap? We explain every term as you browse, in plain English. Same data, with the help built in.

⚡ Expert View
You already know the market. Just the data — clean, fast and compact, with no extra explanations. This is the default view.

Interface language
Security record · archived quarter

CATX

Perspective Therapeutics, Inc. · Healthcare · Medical - Devices

3.17 -3.5% mkt cap $362.10M quote delayed (FMP) · as of Aug 26 15:08 UTC — separate from filing data below

Q2 2026 Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024
6Tracked holders
-2Δ holders
3.54MShares held
$47.23MReported value
+1New positions
−3Exits
Strongly Falling How these are computed → Explain this at the Research Desk →

Momentum inputs (comparable managers): holder breadth -25.0% · share flow -7.0% · net new positions -20.0%formula
Broad distribution — falling shares and fewer holders

All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q3 2024

Ownership over time
QuarterHoldersΔSharesReported valueNewExits
Q2 2026 59 -4 46.71M $159.40M +6 −10
Q1 2026 65 +7 36.59M $152.45M +14 −7
Q4 2025 58 +1 24.82M $68.26M +2 −1
Q3 2025 14 0 27.71M $95.03M +1 −1
Q2 2025 11 0 24.99M $85.98M +1 −1
Q1 2025 8 -1 4.80M $10.23M +1 −2
Q4 2024 9 +2 5.35M $17.08M +3 −1
Q3 2024 6 -2 3.54M $47.23M +1 −3
Q2 2024 8 3.80M $37.75M
Holder count
Who holds it · Q3 2024
#ManagerSharesΔ sharesValueTheir weightHeld
1 Marshall Wace 1.49M +16.1% $19.90M 0.0% ▲ Add 2 SEC ↗
2 Marshall Wace 1.49M +16.1% $19.90M 0.0% ▲ Add 2 SEC ↗
3 Geode Capital Management (passive) 1.16M +12.5% $15.55M 0.0% ▲ Add 2 SEC ↗
4 Geode Capital Management (passive) 1.16M +12.5% $15.55M 0.0% ▲ Add 2 SEC ↗
5 Adage Capital Partners 750.00K +96.5% $10.01M 0.0% ▲ Add 2 SEC ↗
6 Arrowstreet Capital 102.29K New $1.37M 0.0% New 1 SEC ↗
7 T. Rowe Price 17.91K +19.2% $240,000 0.0% ▲ Add 2 SEC ↗
8 Citadel Advisors 12.02K -97.9% $160,520 0.0% ▼ Trim 2 SEC ↗

“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.

New buyers

Arrowstreet Capital $1.37M 0.0%

Exited

Millennium Management $2.46M was 0.0%
Point72 Asset Management $2.02M was 0.0%
Renaissance Technologies $614,750 was 0.0%

Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 135 holders, 78.53M shares, $325.34M reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.

Frequently co-owned

What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.

Provenance: Ownership from parsed 13F common-stock positions (tracked universe, comparable sets for changes); insider rows from Forms 3/4/5; stakes from Schedules 13D/13G; every filing links to its original on SEC EDGAR. Reporting period: Q3 2024 · Methodology · Get this via the API